| Value | ₹6.85 Cr |
|---|
BSE filing, BSE: 503626. Summary written from the filing by ALFA Finder's alert engine.
More from Manglam Global Corporations Ltd
All →Manglam Global Corporations Other Announcement
Manglam Global Corporations Ltd filed its quarterly shareholding pattern as per Regulation 31(1)(b). The document details equity holdings of promoters and public shareholders.
Manglam Global Corporations Annual General Meeting
Manglam Global Corporations announced voting results for its 47th AGM held on July 8, 2026. Shareholders approved all resolutions including financial statement adoption and auditor appointments.
Manglam Global Corporations Merger & Restructuring Worth ₹0.6 Cr
Manglam Global Corporations acquired 100% stake in Manglam Food Products Private Limited. The transaction was valued at ₹0.6 Crore in cash.
- Value
- ₹0.60 Cr
Apollo Ingredients Annual General Meeting
Apollo Ingredients Ltd held its 46th AGM on 29 June 2026, approving all resolutions. The e‑voting results are disclosed in the Scrutinizer’s report to BSE.
Manglam Global Corporations Acquisition Worth ₹0.63 Cr
Manglam Global Corporations acquired 100% stake in Shri Krishnam Industries for ₹0.63 Crore. The move strengthens its agro-processing presence through a new dal manufacturing subsidiary.
- Value
- ₹0.63 Cr
Manglam Global Corporations Q4 FY26 Results: Net Profit ₹0.3 Cr, Up 50.0% YoY
Manglam Global Corporations Ltd reported revenue from operations of ₹10.8 Cr (+176.9% YoY) and net profit of ₹0.3 Cr (+50.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.3 Cr · +50.0% YoY
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.